Our Services
Medical Information
Helpful Resources
Published on: 4/21/2026
Benfotiamine is a lipid soluble form of vitamin B1 that crosses cell membranes more easily than regular thiamine, protecting nerves from high blood sugar by activating key metabolic pathways, reducing harmful sugar byproducts, oxidative stress and inflammation, and improving blood flow to peripheral nerves. Clinical studies show it can reduce pain, improve nerve conduction and lower levels of advanced glycation end products in people with diabetic neuropathy.
There are several factors to consider such as dosing, safety and interactions with other treatments so see below for complete details that can guide your next steps in managing diabetic nerve health.
Diabetic neuropathy—nerve damage caused by chronically high blood sugar—can lead to pain, tingling, numbness and reduced quality of life. Managing blood sugar remains the cornerstone of prevention, but supplements such as benfotiamine have shown promise in supporting nerve health. Below, we explain what benfotiamine is, explore its mechanisms of action, outline the key benfotiamine benefits for diabetic nerves, and review clinical evidence you can discuss with your healthcare provider.
Benfotiamine is a lipid-soluble form of vitamin B₁ (thiamine). Unlike regular thiamine, benfotiamine:
Because of this enhanced absorption, benfotiamine has been studied for its potential to protect nerves and blood vessels from the harmful consequences of high glucose levels.
Researchers believe benfotiamine exerts its nerve-protective effects through several complementary pathways:
Together, these actions address major contributors to diabetic nerve damage and may help restore or preserve normal nerve function.
Clinical and laboratory studies have identified several potential benefits of benfotiamine supplementation in people with diabetic neuropathy:
These benefits can translate to improved daily function, reduced risk of foot ulcers and a better overall quality of life.
While results are encouraging, larger and longer trials would help define optimal dosing and confirm long-term benefits.
Always follow the dosing instructions on your supplement label and discuss any changes with your healthcare provider.
Benfotiamine is considered safe and well-tolerated at commonly recommended doses. Possible mild side effects include:
Because benfotiamine affects thiamine levels, people with thiamine allergies or specific metabolic disorders should use it only under medical supervision. If you experience any unusual or severe reactions, stop use and consult your doctor.
Benfotiamine can be a valuable adjunct to:
It is not a replacement for standard medical treatment but rather an additional tool to help protect and repair nerves. If you're experiencing symptoms such as pain, tingling or numbness in your extremities, you can use a free AI-powered Diabetic Neuropathy symptom checker to better understand your condition and guide your conversation with your healthcare provider.
Always coordinate supplement use with your healthcare team to ensure it fits your overall treatment plan.
Disclaimer: This article is for informational purposes only and does not substitute professional medical advice. If you have serious symptoms—such as uncontrolled blood sugar, severe pain, numbness leading to balance issues or signs of infection—speak to a doctor right away. Before starting any new supplement, including benfotiamine, consult your physician to discuss potential interactions, contraindications and appropriate dosage.
(References)
* Liu S, et al. Benfotiamine and Diabetic Neuropathy: A Systematic Review and Meta-Analysis. J Diabetes Res. 2018;2018:7586541. doi: 10.1155/2018/7586541.
* Xu Y, et al. Benfotiamine for the treatment of diabetic polyneuropathy: a systematic review and meta-analysis of randomized controlled trials. J Diabetes Complications. 2018 Nov;32(11):1088-1096. doi: 10.1016/j.jdiacomp.2018.08.005.
* Gadau M, et al. Benfotiamine: from biochemistry to therapeutic use in diabetic neuropathy. Curr Drug Metab. 2006 Dec;7(8):843-9. doi: 10.2174/138920006778992497.
* Mijnhout GS, et al. Benfotiamine in the treatment of diabetic polyneuropathy: a systematic review and meta-analysis. Exp Clin Endocrinol Diabetes. 2010 Sep;118(8):480-4. doi: 10.1055/s-0030-1249005.
* Wong MC, et al. High-dose thiamine therapy for diabetic peripheral neuropathy: A systematic review and meta-analysis. Diabet Med. 2021 Jun;38(6):e14511. doi: 10.1111/dme.14511.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.